Clinical trial
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
NCT01286350
Study timeline
Study start (unknown)2014-05-01Date precision: month
Registry last updated2021-04-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetesunresolved
Interventions
Sponsors & collaborators
University of North Carolina, Chapel Hilllead sponsor
Children's Hospital Medical Center, Cincinnaticollaborator
University of Colorado, Denvercollaborator
University of Washingtoncollaborator
Nemours Children's Cliniccollaborator
University of Pittsburghcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01286350 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.